Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors-Reference-Cited by-同舟云学术

Single Low-Dose Injection of Evans Blue Modified PSMA-617 Radioligand Therapy Eliminates Prostate-Specific Membrane Antigen Positive Tumors

Published:2018-08-14 Issue:9 Volume:29 Page:3213-3221
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Wang Zhantong¹,Tian Rui¹,Niu Gang¹,Ma Ying¹,Lang Lixin¹,Szajek Lawrence P.²,Kiesewetter Dale O.¹,Jacobson Orit¹,Chen Xiaoyuan¹^ORCID

Affiliation:

1. Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland, United States

2. Positron Emission Tomography Department, Warren Grant Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland, United States

Funder

National Institute of Biomedical Imaging and Bioengineering

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.8b00556

Reference42 articles.

1. Lutetium177PSMA radionuclide therapy for men with prostate cancer: a review of the current literature and discussion of practical aspects of therapy

2. Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer

3. Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy

4. PSMA Ligands for PET Imaging of Prostate Cancer

5. PSMA ligands in prostate cancer – Probe optimization and theranostic applications

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ways to reduce radioactivity accumulation in the kidney during targeted therapy using small molecules, peptides and antibody fragments;Siberian journal of oncology;2024-09-09

2. New tactics in the design of theranostic radiotracers;npj Imaging;2024-08-02

3. FAP Radioligand Linker Optimization Improves Tumor Dose and Tumor-to-Healthy Organ Ratios in 4T1 Syngeneic Model;Journal of Medicinal Chemistry;2024-07-16

4. Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder;Cancers;2024-03-23

5. Radiotheranostics Based on Chemical Control of Radioactivity Pharmacokinetics;YAKUGAKU ZASSHI;2024-03-01